Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prediction of major bleeding events by using CRUSADE and ACUITY risk scores in cohort of Chinese ticagrelor-treated patients with acute coronary syndrome after PCI

Trial Profile

Prediction of major bleeding events by using CRUSADE and ACUITY risk scores in cohort of Chinese ticagrelor-treated patients with acute coronary syndrome after PCI

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Oct 2017

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Acute coronary syndromes
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Oct 2017 New trial record
    • 10 Oct 2017 Results published in the Thrombosis and Haemostasis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top